Profile
Scott Wasserman currently works at Kyttaro Ltd., as Director from 2022.
Scott Wasserman active positions
| Companies | Position | Start |
|---|---|---|
KYTTARO Ltd.
 KYTTARO Ltd. BiotechnologyHealth Technology Kyttaro Ltd. develops monoclonal antibodies for potential treatment of atherosclerotic cardiovascular diseases. The company is based in Oxford, UK. The British company was founded in 2021. The CEO is Douglas Eby. | Director/Board Member | 06/11/2022 |
Experiences
Positions held
Connections
3
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
KYTTARO Ltd.
KYTTARO Ltd. BiotechnologyHealth Technology Kyttaro Ltd. develops monoclonal antibodies for potential treatment of atherosclerotic cardiovascular diseases. The company is based in Oxford, UK. The British company was founded in 2021. The CEO is Douglas Eby. | Health Technology |
- Stock Market
- Insiders
- Scott Wasserman
